Trial Profile
Cystic Fibrosis - Insulin Deficiency, Early Action
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Jun 2023
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Acronyms CF-IDEA
- 29 May 2023 Status changed from active, no longer recruiting to completed.
- 17 Oct 2022 Planned primary completion date changed from 1 Dec 2022 to 1 Feb 2023.
- 17 Oct 2022 Status changed from recruiting to active, no longer recruiting.